R. Biamonte

470 total citations
8 papers, 370 citations indexed

About

R. Biamonte is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, R. Biamonte has authored 8 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in R. Biamonte's work include Intraperitoneal and Appendiceal Malignancies (2 papers), Cancer Treatment and Pharmacology (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). R. Biamonte is often cited by papers focused on Intraperitoneal and Appendiceal Malignancies (2 papers), Cancer Treatment and Pharmacology (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). R. Biamonte collaborates with scholars based in Italy, India and Canada. R. Biamonte's co-authors include Luigi Manzione, Giovanni Di Vagno, Giovanni Scambia, Sandro Pignata, Stefano Greggi, A. De Matteis, Giacomo Cartenì, Saverio Danese, Antonio Febbraro and Sabino De Placido and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

R. Biamonte

8 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Biamonte Italy	5	184	160	134	104	55	8	370
J. Mazurka Canada	10	120 0.7×	177 1.1×	47 0.4×	85 0.8×	170 3.1×	15	488
N. Tsavaris Greece	10	196 1.1×	31 0.2×	70 0.5×	63 0.6×	28 0.5×	38	324
Giulia Scaglione Italy	10	106 0.6×	214 1.3×	50 0.4×	64 0.6×	268 4.9×	58	434
Isabel Alvarado Mexico	11	262 1.4×	21 0.1×	196 1.5×	110 1.1×	42 0.8×	20	457
Asad Haider United States	6	65 0.4×	146 0.9×	33 0.2×	45 0.4×	102 1.9×	13	287
Maktav Dinçer Türkiye	12	113 0.6×	85 0.5×	91 0.7×	60 0.6×	38 0.7×	23	329
G. Rangoni Italy	10	111 0.6×	143 0.9×	69 0.5×	68 0.7×	88 1.6×	26	362
Laura Yébenes Spain	11	134 0.7×	51 0.3×	38 0.3×	93 0.9×	69 1.3×	24	347
Takachika Ozawa Japan	13	118 0.6×	37 0.2×	135 1.0×	101 1.0×	27 0.5×	28	417
Maria Koumpou Greece	8	139 0.8×	80 0.5×	146 1.1×	126 1.2×	7 0.1×	12	321

Countries citing papers authored by R. Biamonte

Since Specialization

Citations

This map shows the geographic impact of R. Biamonte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Biamonte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Biamonte more than expected).

Fields of papers citing papers by R. Biamonte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Biamonte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Biamonte. The network helps show where R. Biamonte may publish in the future.

Co-authorship network of co-authors of R. Biamonte

This figure shows the co-authorship network connecting the top 25 collaborators of R. Biamonte. A scholar is included among the top collaborators of R. Biamonte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Biamonte. R. Biamonte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Biamonte, R., et al.. (2016). ReCaTuR -Rare Cancer Network Calabria -“Implementing a software system based on showing of 3D stereoscopic imaging data”. Annals of Oncology. 27. iv100–iv100. 4 indexed citations

Biamonte, R., et al.. (2009). Advanced adult esthesioneuroblastoma successfully treated with cisplatin and etoposide alternated with doxorubicin, ifosfamide and vincristine. Journal of Neuro-Oncology. 98(1). 131–135. 14 indexed citations

Pignata, Sandro, Sabino De Placido, R. Biamonte, et al.. (2006). Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study. BMC Cancer. 6(1). 5–5. 99 indexed citations

Maio, Marco Di, R. V. Iaffaioli, Sabino De Placido, et al.. (2005). Residual neurotoxicity in patients with ovarian cancer in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trials in Ovarian cancer (MITO-4) retrospective study. Journal of Clinical Oncology. 23(16_suppl). 5015–5015. 3 indexed citations

Placido, Sabino De, Giovanni Scambia, Giovanni Di Vagno, et al.. (2004). Topotecan Compared With No Therapy After Response to Surgery and Carboplatin/Paclitaxel in Patients With Ovarian Cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) Randomized Study. Journal of Clinical Oncology. 22(13). 2635–2642. 118 indexed citations

Lorusso, Domenica, Gabriella Ferrandina, Stefano Greggi, et al.. (2003). Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients. Annals of Oncology. 14(7). 1086–1093. 75 indexed citations

Gadaleta‐Caldarola, Gennaro, et al.. (2002). De Gramont Schedule is a Very Low Toxic and Effective Regimen in Low Performance Status Patients Affected by Metastatic Gastric Cancer: Preliminary Report. Tumori Journal. 88(4). A21–A24. 55 indexed citations

Biamonte, R., et al.. (1998). Knowledge and beliefs about breast cancer prevention in an unselected female Italian population. European Journal of Cancer. 34. S66–S66. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact